(redirected from human insulin)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Related to human insulin: recombinant human insulin
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to insulin

References in periodicals archive ?
diabetes patients during###(HbA1c) and changes in###Group-2: Biphasic human insulin 30###0.
Increasing prevalence of diabetes, increasing number of geriatric population, rising prevalence of obesity and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America.
The global human insulin market research report is divided by geography (regional and country based) into North America (U.
and Canada) is expected to command the largest share of the global human insulin market in 2015, followed by Europe.
56 percentage points and the regular human insulin group by 0.
The researchers have revealed that no difference was found between the short-acting insulin analogues, lispro and aspart, and human insulin.
All are large molecules that are closely related to human insulin and it is unlikely that insulin crosses the placenta, at least in clinically significant amounts, said Mr.
Two insulin assays, one that can specifically quantify human insulin and a second with which human insulin, insulin aspart, and insulin lispro cross-react equally, have been used to estimate the concentration of insulin aspart or lispro by subtraction (5).
She guessed her daughter's problems were caused by human insulin because she herself suffered when she took it years before.
In a study of 59 children treated at six sites in the United States and Canada, subjects were randomly assigned to take insulin lispro 15 minutes before meals, insulin lispro immediately after meals, or human insulin 30-45 minutes before meals, along with regular basal insulin injections.
Doctors believe the animal insulin in cows' milk can turn off human insulin production.
The immune system would attack pancreas islet cells that make human insulin, which resembles bovine insulin, and would produce antibodies.
Biotechnology products already in use on the market include erythropoietin (EPO), granulocyte colony stimulating factors, growth hormone (GH), human insulin, and tissue plasminogen activator (TPA).
The perceived shortage triggered a race to mass-produce human insulin by synthesizing a human insulin gene.
Full browser ?